Us TOO logo
     
News You Can Use
 
  Us TOO Homepage | Donate | View Message in Your Browser | Change Email Preferences | Forward to a Friend
Dear Friend,

I hope that you're doing well. Here's the latest prostate cancer News You Can Use, which provides a recap of some of the most relevant and recent articles.

Hard as it may be to believe, we’re already halfway through September--Prostate Cancer Awareness Month! Thank you to everyone who has registered and/or donated to the 10th Anniversary of the SEA Blue Prostate Cancer Walk & Run in Chicago on Sunday, September 14th. There’s still time to participate; for more information CLICK HERE.

We’re pleased to be partnering with Wearever men’s incontinence briefs (CLICK HERE). Throughout the month of September 10 percent of all proceeds will be donated to Us TOO. Incontinence can be one of the more common side effects resulting from some prostate cancer treatments. Classic incontinence briefs and incontinence Boxer Briefs by Wearever provide another option for dealing with a little leakage. In addition to being washable and reusable, they look and feel more like regular underwear while providing a comfortable fit and absorbent protection that wicks moisture away from the body. Wearever's incontinence briefs are constructed with sewn-in Unique-Dri™ pads and odor eliminating Agion™ antimicrobial fibers. And since each brief or boxer brief should last for 200 to 250 washes, they are more economical than disposables. Find out more at www.weareverincontinence.com

Headlines of the articles are listed below and the full text is available at: http://www.ustoo.org/Prostate_Cancer_News.asp


* ASTELLAS -U.S. FDA Approves New Indication for the Use of XTANDI (enzalutamide) Capsules for Patients with Metastatic Castration-Resistant Prostate Cancer 
* Presidential Proclamation -- National Prostate Cancer Awareness Month, 2014
* RNA sequence could help doctors to tailor unique prostate cancer treatment programs 
* New recommendations for post-treatment care of prostate cancer survivors
* Prostate cancer drug candidate shows great promise
* New Prostate Cancer Study Findings Reported from University of Kentucky (Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate...
* Version 2.0 of Prostate Cancer Risk Calculator now online, complete with emojis 
* Tests could help men with prostate cancer 
* Blood test for 'nicked' protein predicts prostate cancer treatment response 
* ASCO and Cancer Care Ontario Issue New Guideline on Treating Metastatic Castration-Resistant Prostate Cancer 
* New Prostate Cancer Study Results Reported from Johns Hopkins University School of Medicine (The role of inflammation in prostate cancer)
* Men who are uneducated about their prostate cancer have difficulty making good treatment choices 
* Age and Genetics Play a Key Role in Prostate Cancer Occurrence 

* Fighting prostate cancer with a tomato-rich diet

Watch for the October issue of the HotSheet in about two weeks and look for more News You Can Use next month! 

My best to you,

Thomas Kirk
President & CEO
Us TOO International
Des Plaines, IL 60018
Office: 630-795-1002
Toll Free: 800-808-7866
tom@ustoo.org
Tom Kirk 14
 
Donate Now!

Circles of Love National Health Council GreatNonprofits.jpg
Us TOO International Facebook Us TOO International Twitter Us TOO International LinkedIn
  Us TOO International YouTube Us TOO International Inspire Community  
 

Us TOO International Prostate Cancer Education & Support Network
www.ustoo.org 

2720 S. River Road, Suite 112, Des Plaines, IL 60018-4106
P: 630-795-1002  F: 630-795-1602   
PCa HelpLine: 1-800-80-Us TOO (808-7866)